AT845 gene replacement therapy for late onset Pompe disease: Overview of clinical data from FORTIS, a phase 1/2 open-label clinical study Mozaffar, T., Day, J. W., Longo, N., Manera, J., Straub, V., Maruoka, M., Han, C., Foo, C., Smith, A. R., Bachtell, N. ACADEMIC PRESS INC ELSEVIER SCIENCE. 2022: S85-S86

View details for DOI 10.1016/j.ymgme.2021.11.221

View details for Web of Science ID 000803066100208